Neurobiology of Opioid Dependence: 1 - 1
NCT00000192 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-08-07
Summary
The purpose of this study is to evaluate the effects of lamotrigine on naloxone-precipitated opiate withdrawal.
Conditions
- Opioid-Related Disorders
Interventions
- DRUG
-
Lamotrigine
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Yale University
lead OTHER
Principal Investigators
-
Marc I Rosen, M.D. · VA Connecticut Healthcare System
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1993-01-31
- Primary Completion
- 1998-01-31
- Completion
- 1998-01-31
Countries
- United States
Study Locations
More Related Trials
-
Endogenous Opioid Modulation by Ketamine
NCT03051945 ·Status: WITHDRAWN ·Phase: PHASE3
-
Cannabioids as a New Intervention for Amphetamine Dependence
NCT02952196 ·Status: WITHDRAWN ·Phase: PHASE2
-
Oral and IV Baclofen in Adult Volunteers
NCT01749319 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
NCT03143855 ·Status: COMPLETED ·Phase: PHASE1
-
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
NCT02643355 ·Status: COMPLETED ·Phase: NA
-
Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
NCT02557984 ·Status: COMPLETED ·Phase: NA
-
Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System
NCT03854942 ·Status: TERMINATED ·Phase: PHASE1
-
Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior Development
NCT01020669 ·Status: COMPLETED
-
Cannabinoids, Neural Synchrony, and Information Processing
NCT00708994 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Cannabinoids, Learning, and Memory
NCT02407808 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
NCT03679949 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers
NCT05235503 ·Status: UNKNOWN ·Phase: PHASE4
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
NCT03773523 ·Status: RECRUITING ·Phase: NA
-
Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers
NCT03481192 ·Status: UNKNOWN ·Phase: NA
-
N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms
NCT03221231 ·Status: UNKNOWN ·Phase: PHASE4
-
Behavioral Pharmacology of THC and D-limonene
NCT03609853 ·Status: COMPLETED ·Phase: PHASE1
-
THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis
NCT04199468 ·Status: COMPLETED ·Phase: PHASE1
-
Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients
NCT00184184 ·Status: COMPLETED
-
Opioid and Cannabinoid Interactions
NCT03705559 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Oxytocin on Craving and Therapy Response
NCT01827332 ·Status: COMPLETED ·Phase: NA
-
The Effects of Fentanyl Abuse on Executive Function and Related Brain Activity
NCT05469217 ·Status: UNKNOWN
-
Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin
NCT03011970 ·Status: COMPLETED ·Phase: PHASE1
-
Stanford Regulating Circuits of the Brain Study- Ketamine
NCT03475277 ·Status: COMPLETED
-
A First Study in Healthy Volunteers of a New Mobile Phone Application Measuring the Eyes Before and After Medication
NCT05731999 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant Users
NCT00902772 ·Status: COMPLETED ·Phase: PHASE1